TJX

TJX Companies

$139.62

+0.15%
Nov 20, 2026
Bobby Quantitative Model
TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries through four segments — Marmaxx (T.J. Maxx/Marshalls), HomeGoods, TJX Canada, and TJX International — selling branded merchandise at meaningful discounts sourced through a flexible, opportunistic buying model. Its scale, deep vendor relationships, and rapid inventory turnover make it the dominant platform in off-price retail, a structurally advantaged niche that has historically gained share when consumers trade down and full-price retailers are stuck with excess inventory. The current investor debate centers on a sharp divergence between operational execution and stock performance: TJX posted a strong fiscal Q2 2027 with 5.4% revenue growth and raised its full-year outlook, yet the shares fell roughly 15% in August after full-year profit guidance disappointed and two analysts downgraded on valuation concerns. The narrative has shifted from 'best-in-class compounder' to 'how much should you pay for mid-single-digit comps,' particularly as rival Ross Stores posted 10% comparable sales growth against TJX's 4%, raising questions about relative momentum within off-price.

People also watch

Ross Dress for Less

Ross Dress for Less

ROST

Analysis
Burlington

Burlington

BURL

Analysis
Victoria’s Secret

Victoria’s Secret

VSXY

Analysis
Gap Inc.

Gap Inc.

GAP

Analysis
Urban Outfitters

Urban Outfitters

URBN

Analysis

BobbyInvestment Opinion: Should I buy TJX Today?

Rating: Hold with a constructive bias toward accumulating on weakness. The core thesis is that TJX remains a structurally advantaged off-price compounder whose 268 basis point gross margin expansion and $5.88 billion TTM free cash flow are intact, but the stock's 30.6x trailing / 23.4x forward multiple and 4% comps versus Ross Stores' 10% leave the risk/reward balanced until a comparable-sales catalyst emerges. The analyst consensus of 'buy' (mean rating 1.65 across 20 analysts, 18 Buy / 5 Hold / 0 Sell) with a $167.50 average target implies 24.7% upside from $134.37, anchoring the constructive side of the view.

Supporting evidence: (1) Valuation is premium but compressing — 23.4x forward PE on consensus FY EPS of $7.05 versus 30.6x trailing, a ~24% de-rating that already discounts some growth moderation, though the 2.28 PEG and 2.79x PS still sit well above apparel retail peers in the mid-to-high teens. (2) Profitability is improving — Q2 fiscal 2027 net income rose 22.6% to $1.52 billion on 5.41% revenue growth, with net margin up to 10.01% from 8.63% and operating margin at 13.09% from 11.25%. (3) Cash generation is self-funding — $1.73 billion of Q2 FCF covered $531 million of dividends and $814 million of buybacks while cash grew to $6.00 billion, and the 3.5% FCF yield supports the multiple. (4) The entire published analyst target range ($136.00 low to $190.00 high) sits above the current price, and the stock trades at just 24.5% of its 52-week range after a -27.06% max drawdown, suggesting much bad news is priced.

Risks and conditions: The three biggest threats are (a) comps decelerating further and ceding share to Ross Stores, (b) multiple compression from 23.4x forward toward the high-teens/low-20s historical trough, and (c) a holiday guidance miss that triggers further downgrades beyond the Jefferies Hold and Citigroup Neutral moves. This Hold would upgrade to Buy if holiday comps reaccelerate toward high single digits or the forward PE compresses below ~20x while EPS estimates hold; it would downgrade to Sell if comps fall to low single digits, gross margin slips back below ~31%, or the $122.78 52-week low breaks on volume. Verdict: fairly valued to modestly rich relative to its own history and at a clear premium to peers — not a bargain, but a quality name where the 24.7% implied upside to the $167.50 target compensates patient holders for waiting on a comps inflection.

Sign up to view all

TJX 12-Month Price Forecast

TJX presents a genuinely balanced setup: the operating business is executing well with expanding margins and robust free cash flow, but the stock's premium multiple and lagging comps versus Ross Stores have driven a -23.53% relative-strength gap versus the S&P 500 and a -27.06% max drawdown. The 23.4x forward PE already reflects a ~24% de-rating from the 30.6x trailing multiple, and the entire analyst target range sits above the current price, which tilts the risk/reward modestly positive for patient investors. However, with the stock at just 24.5% of its 52-week range and momentum negative across every window, there is no technical confirmation of a bottom, and the market is clearly waiting for a comps catalyst before re-rating the shares. I would upgrade to bullish if holiday comps reaccelerate toward high single digits or the forward PE compresses below ~20x with estimates intact, and downgrade to bearish if comps fall to low single digits or the $122.78 low breaks. Confidence is medium because the fundamental case is solid but the near-term catalyst path is genuinely uncertain.

Historical Price
Current Price $139.62
Average Target $153.75
High Target $190.00
Low Target $122.78

Wall Street consensus

Most Wall Street analysts maintain a constructive view on TJX Companies's 12-month outlook, with a consensus price target around $165.55 and implied upside of +18.6% versus the current price.

Average Target

$165.55

23 analysts

Implied Upside

+18.6%

vs. current price

Analyst Count

23

covering this stock

Price Range

$135 - $190

Analyst target range

Buy
17 (74%)
Hold
6 (26%)
Sell
0 (0%)

Coverage is deep and predominantly bullish: 20 analysts cover TJX with 18 Buy ratings, 5 Hold ratings, and zero Sells, yielding a consensus recommendation of 'buy' (mean rating 1.65 on a 1-5 scale where 1 is Strong Buy). The average target price of $167.50 implies roughly 24.7% upside from the current $134.37, a wide gap that suggests analysts view the August selloff as an overreaction to guidance rather than a fundamental deterioration. Recent institutional actions are mixed but lean constructive — UBS and BofA reiterated Buy in late October and early November, while Jefferies downgraded to Hold from Buy in late August and Citigroup moved to Neutral from Buy, indicating some valuation-driven caution even among the bulls.

The target range of $136.00 to $190.00 is wide (a 40% spread from low to high), signaling genuine disagreement about the growth trajectory. The $190 high target likely assumes comps reaccelerate toward high single digits, margin expansion continues (gross margin already at 33.4%), and the multiple re-rates back toward 30x forward earnings — essentially a 'quality compounder restored' scenario. The $136 low target, barely above the current price, prices in continued comp deceleration, competitive pressure from Ross Stores, and multiple compression toward the low-20s, essentially a 'value trap' scenario. The concentration of targets above $160 (given the $167.50 average) suggests most analysts see the current price as a buying opportunity, but the recent downgrades and the stock's failure to hold rallies indicate the market is not yet convinced — a setup where positive catalysts (holiday comps, margin beats) could drive sharp mean-reversion upside, while a weak Q3 print risks testing the $122.78 52-week low.

Drowning in data?

Find the real signal!

Bulls vs Bears: TJX Investment Factors

The bear case currently has stronger near-term evidence: the stock is in an accelerating downtrend, comps trail Ross Stores 4% to 10%, guidance disappointed, and two analysts downgraded on valuation — all against a 30.6x trailing multiple that prices in perfection. The bull case rests on a longer horizon: 18 of 20 analysts rate Buy with a $167.50 average target, margins expanded 268 basis points, and $5.88 billion of TTM free cash flow funds buybacks and dividends without external financing. The single most important tension is whether TJX's 4% comps are a temporary air pocket or structural share loss to Ross — if holiday comps reaccelerate toward high single digits, the 23.4x forward multiple looks cheap and mean-reversion toward $167 is likely; if they decelerate further, the multiple compresses toward the low-20s and the $122.78 low gets tested. At $134.37 the risk/reward is asymmetric to the upside given the entire analyst target range sits above the price, but the market is waiting for a comps catalyst before re-rating the stock.

Bullish

  • Analyst consensus firmly bullish with 25% upside: 18 of 20 analysts rate TJX Buy with zero Sells, a mean rating of 1.65, and an average target of $167.50 — implying 24.7% upside from the $134.37 price. Even the lowest target of $136.00 sits above the current price, meaning the entire published target range is above where the stock trades today.
  • Margins expanding sharply year-over-year: Q2 fiscal 2027 gross margin rose 268 basis points to 33.41% from 30.73%, lifting net margin to 10.01% from 8.63% and operating margin to 13.09% from 11.25%. Net income grew 22.6% to $1.52 billion on only 5.4% revenue growth, demonstrating real operating leverage despite the modest top line.
  • Self-funding cash machine with buybacks: TJX generated $1.73 billion of free cash flow in Q2 alone on $2.23 billion operating cash flow, comfortably covering $531 million of dividends and $814 million of buybacks. TTM FCF of $5.88 billion against a $168.5 billion market cap yields roughly 3.5%, and cash grew to $6.00 billion with no reliance on external financing.
  • Defensive low-beta profile at a discount: With a beta of just 0.587, TJX is roughly 41% less volatile than the market, and the stock now trades at only 24.5% of its 52-week range ($122.78–$170.00) after a -27.06% max drawdown. Much of the bad news appears discounted, and the 23.4x forward PE is well below the 30.6x trailing multiple, implying the market already expects earnings to grow into the valuation.

Bearish

  • Comps badly trailing Ross Stores: TJX posted 4% comparable sales growth against Ross Stores' 10%, a widening momentum gap within off-price that undermines TJX's 'best-in-class' positioning. The market has begun pricing relative share loss, and the August selloff accelerated precisely on this comparison.
  • Premium valuation leaves no room for error: At 30.6x trailing and 23.4x forward earnings, a 2.28 PEG ratio, 2.79x PS, and 20.6x EV/EBITDA, TJX trades at roughly a 60–80% premium to apparel retail peers in the mid-to-high teens. The August 15% drop on a guidance miss showed how quickly a premium multiple can compress on modest disappointment.
  • Profit guidance miss triggered downgrades: Despite a Q2 revenue and earnings beat, full-year profit guidance disappointed and two analysts downgraded — Jefferies to Hold and Citigroup to Neutral — on valuation concerns. The stock has failed to hold rallies since, with the November 4 spike to $144.76 reversing to $135.30 within two days.
  • Persistent idiosyncratic downtrend: TJX is down 12.91% YTD versus the S&P 500's +10.62%, a -23.53% relative-strength gap, and down 11.66% over three months with the one-month decline (-5.92%) accelerating. Negative relative strength across every window (-3.66% 1M, -8.83% 3M, -10.99% 6M) confirms stock-specific distribution rather than sector rotation.

TJX Technical Analysis

TJX is in a clear intermediate downtrend within a broader range, with the stock down 8.22% over the past year and 12.91% year-to-date, badly lagging the S&P 500's +12.27% one-year and +10.62% YTD returns (relative strength of -20.49% and -23.53%, respectively). At $134.37, the stock sits at just 24.5% of its 52-week range of $122.78 to $170.00 — near the lower quartile — which signals persistent distribution rather than a healthy pullback, though it also means much of the bad news may be discounted. The 52-week high of $170.00 was set in the spring, and the stock has given back roughly 21% from that peak, with a max drawdown of -27.06% underscoring how violent the de-rating has been for a historically low-beta name.

Short-term momentum is decisively negative and accelerating to the downside: the stock is down 5.92% over the past month and 11.66% over three months, with the one-month decline outpacing the three-month decline in annualized terms, indicating selling pressure has intensified rather than stabilized. This is a bearish divergence from the longer-term trend — the one-year decline of 8.22% is milder than the three-month drop of 11.66%, meaning the deterioration is recent and momentum-driven, not a slow bleed. Relative strength versus the S&P is negative across every window (-3.66% one-month, -8.83% three-month, -10.99% six-month), confirming this is idiosyncratic weakness rather than sector-wide rotation, and the recent price action around the $134-145 zone shows failed rallies (the November 4 spike to $144.76 quickly reversed to $135.30 by November 6).

Key technical support sits at the 52-week low of $122.78, roughly 8.6% below the current $134.37 — a breakdown there would confirm the downtrend and likely trigger momentum-driven selling toward new lows. Resistance is layered: the $145-147 area (recent November highs) is the first hurdle, while the $170.00 52-week high represents the full recovery level and would require a 26.5% rally. With a beta of just 0.587, TJX is roughly 41% less volatile than the market, which historically made it a defensive holding — but the -27.06% max drawdown shows that low beta offered little protection during this stock-specific de-rating, meaning position sizing should account for idiosyncratic risk rather than relying on the low-beta cushion.

Beta

0.59

0.59x market volatility

Max Drawdown

-27.1%

Largest decline past year

52-Week Range

$123-$170

Price range past year

Annual Return

-5.7%

Cumulative gain past year

PeriodTJX ReturnS&P 500
1m-4.1%-9.7%
3m-0.6%-9.9%
6m-11.8%-7.5%
1y-5.7%+4.7%
ytd-9.5%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TJX Fundamental Analysis

Revenue growth remains solid but is decelerating relative to expectations: fiscal Q2 2027 revenue came in at $15.18 billion, up 5.41% year-over-year from $14.40 billion, a modest sequential acceleration from Q1's $14.32 billion (which grew roughly 9.2% off a soft $13.11 billion base). The segment mix shows Marmaxx at $9.11 billion (60% of quarterly sales) as the core engine, HomeGoods at $2.51 billion, TJX International at $2.09 billion, and TJX Canada at $1.47 billion — a diversified base where no single segment is collapsing, but the 4% comparable sales growth trails Ross Stores' 10%, suggesting TJX is ceding relative momentum within off-price. The raised fiscal 2027 outlook signals management confidence in continued mid-single-digit growth, but the market's negative reaction to profit guidance implies investors expected more operating leverage on that revenue.

Profitability is robust and improving: Q2 2027 net income of $1.52 billion on $15.18 billion revenue produced a 10.01% net margin, up from 8.63% in the year-ago quarter ($1.24 billion on $14.40 billion), while gross margin expanded to 33.41% from 30.73% — a 268 basis point improvement that reflects better merchandise margins and freight normalization. Operating income rose to $1.99 billion (13.09% operating margin) from $1.62 billion (11.25%), and the trailing gross margin of 30.96% and operating margin of 11.89% are consistent with off-price retail's structural economics, where low SG&A and rapid turns offset thin per-unit margins. The Q1 2027 quarter showed gross margin of 31.28% and net margin of 9.30%, confirming the margin trajectory is upward across recent quarters rather than a one-off, though the Q4 2026 gross margin of 30.86% shows some seasonal variability.

Balance sheet and cash generation are healthy but not fortress-like: debt-to-equity of 1.32 reflects a leveraged but manageable capital structure (typical for retailers that lease heavily and buy back stock), the current ratio of 1.14 is adequate though not generous, and ROE of 53.9% is exceptionally high — flattered by leverage and buybacks but still indicative of strong returns on capital. Trailing free cash flow of $5.88 billion against a $168.5 billion market cap implies an FCF yield of roughly 3.5%, and Q2 2027 alone generated $1.73 billion of FCF on $2.23 billion operating cash flow after $497 million capex, comfortably covering $531 million of dividends and $814 million of buybacks. The company is self-funding: it returned roughly $1.35 billion to shareholders in Q2 while still growing cash to $6.00 billion, meaning it does not depend on external financing — a meaningful strength given the elevated payout ratio of 33.5% and dividend yield of just 1.09%.

Quarterly Revenue

$16.0B

2026-10

Revenue YoY Growth

+5.5%

YoY Comparison

Gross Margin

32.9%

Latest Quarter

Free Cash Flow

$6.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

HomeGoods
Marmaxx
TJX Canada
TJX International

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TJX Overvalued?

Because TJX is solidly profitable (Q2 2027 net income of $1.52 billion, TTM net margin of 9.10%), the PE ratio is the appropriate primary metric. The stock trades at 30.6x trailing earnings but only 23.4x forward earnings (on consensus FY EPS of $7.05), a roughly 24% compression that implies the market expects meaningful earnings growth to 'grow into' the multiple — consistent with the raised guidance but also leaving little room for disappointment, as the August selloff demonstrated. The PEG ratio of 2.28 suggests investors are paying more than 2x the growth rate for the earnings stream, a premium that requires sustained high-single-digit EPS growth to justify.

Against the broader apparel retail industry, TJX's 30.6x trailing PE and 2.79x PS represent a clear premium — off-price peers and department stores typically trade in the mid-to-high teens on earnings, implying TJX commands roughly a 60-80% premium to the sector. That premium is partly earned: a 53.9% ROE, 33.4% gross margin, and the dominant scale position in off-price justify a quality premium, but the gap versus Ross Stores (which is growing comps faster) narrows the relative case. The EV/EBITDA of 20.6x and price-to-cash-flow of 24.5x are also rich for a retailer, reinforcing that TJX is priced as a quality compounder rather than a value retail name.

On its own history, TJX is not cheap: the current 30.6x trailing PE sits near the top of its multi-year band, which ranged from roughly 19x (early 2024) to 35x (Q1 2025), and the PS ratio of 2.79x (on the current market cap basis) compares to historical price-sales readings in the 6-12x range on a per-share basis during 2024-2026 — the elevated end of that range. The stock's de-rating from 35x to 30.6x trailing PE reflects the market recalibrating growth expectations downward, but at 23.4x forward the valuation is more defensible if EPS growth materializes. The risk is that if comps decelerate further toward low single digits, the multiple could compress toward the high-teens/low-20s historical trough, implying meaningful downside from current levels even without an earnings miss.

PE

30.6x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 19x~35x

vs. Industry Avg

20.5x

Industry PE ~20.5x*

EV/EBITDA

20.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on a premium multiple that depends on continued earnings growth. At 30.6x trailing and 23.4x forward earnings with a 2.28 PEG ratio, TJX must deliver sustained high-single-digit EPS growth to justify its valuation, and the August 15% selloff on a profit-guidance miss proved how little tolerance the market has for shortfalls. Revenue growth of just 5.41% YoY in Q2 is thin relative to that multiple, and the 4% comps trail Ross Stores' 10%, raising the risk of relative share loss within off-price. Debt-to-equity of 1.32 and a current ratio of only 1.14 leave a leveraged but manageable balance sheet, while the 33.5% payout ratio and 1.09% dividend yield mean income support is minimal if the stock continues to de-rate. The 53.9% ROE is flattered by leverage and buybacks, so it overstates underlying returns if the buyback pace slows.

Market and competitive risks are dominated by valuation compression and relative momentum. TJX's 30.6x trailing PE and 2.79x PS represent a roughly 60–80% premium to apparel retail peers in the mid-to-high teens, and the multiple sits near the top of its multi-year 19x–35x band — leaving more room to compress than expand. Ross Stores' accelerating comps and raised guidance make it a more compelling relative holding at similar valuations, and the Jefferies and Citigroup downgrades signal that even bulls are questioning the price. With a beta of 0.587, TJX is 41% less volatile than the market, but that low-beta cushion offered little protection during the -27.06% max drawdown, confirming the risk is idiosyncratic rather than macro. Fed Chair Warsh's 'no tolerance' for inflation stance and the risk of further rate hikes add a macro layer that pressures premium-multiple consumer names.

Worst-case scenario: holiday comps decelerate toward low single digits, Ross continues to outgrow TJX, and the multiple compresses from 23.4x forward toward the high-teens/low-20s historical trough. In that chain, the stock breaks the $122.78 52-week low — roughly 8.6% below the current $134.37 — and momentum selling could extend toward the $110–115 zone, implying a 15–18% loss from today's price. The analyst low target of $136.00 offers little downside cushion since it sits barely above the current price, and the -27.06% max drawdown shows a full de-rating from the $170.00 high would take the stock to roughly $124. An investor should size positions for a realistic 10–20% further downside rather than relying on the low-beta profile for protection.

FAQ

The most severe risk is valuation compression: at 30.6x trailing and 23.4x forward earnings with a 2.28 PEG, TJX trades at roughly a 60-80% premium to apparel retail peers, and the August 15% selloff on a profit-guidance miss proved how quickly that premium can unwind. Second is relative competitive momentum — TJX's 4% comps trail Ross Stores' 10%, and Ross's accelerating growth at similar valuations makes it a more compelling relative holding, raising the risk of continued share loss within off-price. Third is company-specific earnings sensitivity: revenue growth of just 5.41% YoY is thin relative to the multiple, and the raised fiscal 2027 outlook still disappointed on profit, showing the market demands more operating leverage than management delivered. Fourth is macro and rate risk — Fed Chair Warsh's 'no tolerance' inflation stance and the possibility of further hikes pressure premium-multiple consumer names, and although TJX's 0.587 beta is 41% less volatile than the market, that low-beta profile offered little protection during the -27.06% max drawdown, confirming the risk is idiosyncratic rather than market-driven.

The 12-month forecast is split three ways: a 50% base case targeting $140-$167.50, a 25% bull case targeting $167.50-$190.00, and a 25% bear case targeting $122.78-$136.00. The base case is most likely and assumes comps stabilize in the 3-5% range (roughly matching Q2's 4%), gross margin holds in the 31-33% band, and EPS tracks the $7.05 consensus, letting the 23.4x forward multiple be sustained as the stock grinds toward the $167.50 average target. The bull case requires holiday and spring comps reaccelerating toward high single digits with gross margin above 33%, driving a re-rating toward the high-20s/low-30s forward range and the $190 high target. The bear case assumes comps decelerate to low single digits while Ross outgrows TJX, compressing the multiple toward the high-teens/low-20s trough and breaking the $122.78 low toward $110-115. The key assumption behind the most likely outcome is that the August guidance disappointment was a one-off rather than the start of a deceleration trend.

TJX is fairly valued to modestly rich on its own history and clearly at a premium to peers. The stock trades at 30.6x trailing earnings but only 23.4x forward earnings on the $7.05 consensus EPS — a roughly 24% de-rating that already discounts some growth moderation — yet the 2.28 PEG ratio means investors pay more than twice the growth rate for the earnings stream. Against apparel retail peers in the mid-to-high teens, the 2.79x PS, 20.6x EV/EBITDA, and 16.5x price-to-book represent a roughly 60-80% premium, justified partly by a 53.9% ROE and dominant off-price scale but narrowed by Ross Stores growing comps at 10% versus TJX's 4%. On its own multi-year band of roughly 19x to 35x trailing PE, the current 30.6x sits in the upper-middle, implying the market expects TJX to grow into its multiple rather than re-rate higher. In short, the valuation implies sustained high-single-digit EPS growth; if comps drift to low single digits, the multiple could compress toward the high-teens/low-20s trough even without an earnings miss.

From a risk/reward standpoint TJX is reasonably attractive but not a screaming bargain: at $134.37 the stock sits 24.7% below the $167.50 average analyst target, and even the lowest published target of $136.00 is above the current price, meaning the entire analyst range implies upside. The downside is quantifiable — the $122.78 52-week low is about 8.6% below today's price, and a full multiple compression toward the high-teens/low-20s historical trough could extend losses to 15-18% in the $110-115 zone. The fundamental support is real: 18 of 20 analysts rate Buy with zero Sells, gross margin expanded 268 basis points to 33.41%, and $5.88 billion of TTM free cash flow funds both the 1.09% dividend and buybacks. It is a good buy primarily for patient investors with a 12-24 month horizon who want low-beta (0.587) consumer exposure and can wait for a comps catalyst; momentum traders should wait for the stock to reclaim the $145-147 resistance zone before committing.

TJX is better suited to a long-term hold than a short-term trade. The business is a mature, cash-generative compounder — $5.88 billion of TTM free cash flow, a 3.5% FCF yield, a 33.5% payout ratio, and a modest 1.09% dividend yield — with a beta of just 0.587, which argues for patient ownership rather than momentum trading. But the near-term technical picture is decisively negative: the stock is down 5.92% over one month, 11.66% over three months, and 12.91% YTD versus the S&P 500's +10.62%, with relative strength negative across every window and failed rallies at $144.76 reversing to $135.30 within two days. Earnings visibility is decent but not exceptional — the $6.93-$7.19 analyst EPS range is tight, yet the market's reaction to guidance shows sentiment is fragile. A concrete minimum holding period of 12-24 months is appropriate to capture the comps inflection and the path toward the $167.50 average target; short-term traders should wait for a reclaim of the $145-147 resistance zone or a successful retest of the $122.78 low before entering.